These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 25361920)

  • 1. Pathogenesis of post primary tuberculosis: immunity and hypersensitivity in the development of cavities.
    Hunter RL; Actor JK; Hwang SA; Karev V; Jagannath C
    Ann Clin Lab Sci; 2014; 44(4):365-87. PubMed ID: 25361920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculosis as a three-act play: A new paradigm for the pathogenesis of pulmonary tuberculosis.
    Hunter RL
    Tuberculosis (Edinb); 2016 Mar; 97():8-17. PubMed ID: 26980490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Pathogenesis of Tuberculosis: The Early Infiltrate of Post-primary (Adult Pulmonary) Tuberculosis: A Distinct Disease Entity.
    Hunter RL
    Front Immunol; 2018; 9():2108. PubMed ID: 30283448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathology of post primary tuberculosis of the lung: an illustrated critical review.
    Hunter RL
    Tuberculosis (Edinb); 2011 Nov; 91(6):497-509. PubMed ID: 21733755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis and Animal Models of Post-Primary (Bronchogenic) Tuberculosis, A Review.
    Hunter RL; Actor JK; Hwang SA; Khan A; Urbanowski ME; Kaushal D; Jagannath C
    Pathogens; 2018 Feb; 7(1):. PubMed ID: 29415434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Pathogenesis of Tuberculosis-The Koch Phenomenon Reinstated.
    Hunter RL
    Pathogens; 2020 Oct; 9(10):. PubMed ID: 33020397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural and trained innate immunity against Mycobacterium tuberculosis.
    Ferluga J; Yasmin H; Al-Ahdal MN; Bhakta S; Kishore U
    Immunobiology; 2020 May; 225(3):151951. PubMed ID: 32423788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphoproteomics Identifies the Foamy Alveolar Macrophage as an M2 Phenotype with PD-L1 Expression in the Early Lesion of Post-Primary Tuberculosis: Implications for Host Immune Surveillance and Therapy.
    Hwang SA; Ali Y; Fedotova E; Hunter RL; Brown RE
    Ann Clin Lab Sci; 2020 Jul; 50(4):429-438. PubMed ID: 32826237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Tuberculous Granuloma and Preexisting Immunity.
    Cohen SB; Gern BH; Urdahl KB
    Annu Rev Immunol; 2022 Apr; 40():589-614. PubMed ID: 35130029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple roles of cord factor in the pathogenesis of primary, secondary, and cavitary tuberculosis, including a revised description of the pathology of secondary disease.
    Hunter RL; Olsen MR; Jagannath C; Actor JK
    Ann Clin Lab Sci; 2006; 36(4):371-86. PubMed ID: 17127724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunopathology of Pulmonary
    Kolloli A; Kumar R; Venketaraman V; Subbian S
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In mice, tuberculosis progression is associated with intensive inflammatory response and the accumulation of Gr-1 cells in the lungs.
    Lyadova IV; Tsiganov EN; Kapina MA; Shepelkova GS; Sosunov VV; Radaeva TV; Majorov KB; Shmitova NS; van den Ham HJ; Ganusov VV; De Boer RJ; Racine R; Winslow GM
    PLoS One; 2010 May; 5(5):e10469. PubMed ID: 20454613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human lung immunity against Mycobacterium tuberculosis: insights into pathogenesis and protection.
    Schwander S; Dheda K
    Am J Respir Crit Care Med; 2011 Mar; 183(6):696-707. PubMed ID: 21075901
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Ryndak MB; Laal S
    Front Cell Infect Microbiol; 2019; 9():299. PubMed ID: 31497538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterium tuberculosis with different virulence reside within intact phagosomes and inhibit phagolysosomal biogenesis in alveolar macrophages of patients with pulmonary tuberculosis.
    Ufimtseva E; Eremeeva N; Bayborodin S; Umpeleva T; Vakhrusheva D; Skornyakov S
    Tuberculosis (Edinb); 2019 Jan; 114():77-90. PubMed ID: 30711161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SP110b Controls Host Immunity and Susceptibility to Tuberculosis.
    Leu JS; Chen ML; Chang SY; Yu SL; Lin CW; Wang H; Chen WC; Chang CH; Wang JY; Lee LN; Yu CJ; Kramnik I; Yan BS
    Am J Respir Crit Care Med; 2017 Feb; 195(3):369-382. PubMed ID: 27858493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling Mycobacterium tuberculosis early granuloma formation in experimental human lung tissue.
    Parasa VR; Rahman MJ; Ngyuen Hoang AT; Svensson M; Brighenti S; Lerm M
    Dis Model Mech; 2014 Feb; 7(2):281-8. PubMed ID: 24203885
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.